The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 12, 2016
Filed:
Nov. 25, 2014
Applicant:
Boehringer Ingelheim International Gmbh, Ingelheim am Rhein, DE;
Inventors:
Iain Lingard, Monza, IT;
Dieter Hamprecht, Pozzolengo, IT;
Assignee:
Boehringer Ingelheim International GmbH, Ingelheim am Rhein, DE;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/5375 (2006.01); A61K 31/351 (2006.01); A61K 31/195 (2006.01); A61K 31/194 (2006.01); A61K 31/192 (2006.01); A61K 31/277 (2006.01); C07D 213/61 (2006.01); C07D 213/62 (2006.01); C07D 213/64 (2006.01); C07D 215/20 (2006.01); C07D 231/12 (2006.01); C07D 231/56 (2006.01); C07D 249/08 (2006.01); C07D 257/04 (2006.01); C07D 271/07 (2006.01); C07D 277/64 (2006.01); C07D 295/155 (2006.01); C07D 295/18 (2006.01); C07D 295/192 (2006.01); C07D 309/10 (2006.01); A61K 45/06 (2006.01); C07D 309/12 (2006.01); C07C 317/18 (2006.01); C07C 65/26 (2006.01); C07C 235/46 (2006.01); C07C 235/48 (2006.01); C07D 309/14 (2006.01); C07C 255/54 (2006.01); C07C 317/22 (2006.01); C07D 271/06 (2006.01); C07D 295/088 (2006.01); C07C 62/34 (2006.01);
U.S. Cl.
CPC ...
A61K 31/277 (2013.01); A61K 31/192 (2013.01); A61K 31/194 (2013.01); A61K 31/195 (2013.01); A61K 31/351 (2013.01); A61K 31/5375 (2013.01); A61K 45/06 (2013.01); C07C 62/34 (2013.01); C07C 65/26 (2013.01); C07C 235/46 (2013.01); C07C 235/48 (2013.01); C07C 255/54 (2013.01); C07C 317/18 (2013.01); C07C 317/22 (2013.01); C07D 213/61 (2013.01); C07D 213/62 (2013.01); C07D 213/64 (2013.01); C07D 215/20 (2013.01); C07D 231/12 (2013.01); C07D 231/56 (2013.01); C07D 249/08 (2013.01); C07D 257/04 (2013.01); C07D 271/06 (2013.01); C07D 277/64 (2013.01); C07D 295/088 (2013.01); C07D 295/155 (2013.01); C07D 295/18 (2013.01); C07D 295/192 (2013.01); C07D 309/10 (2013.01); C07D 309/12 (2013.01); C07D 309/14 (2013.01); C07C 2102/02 (2013.01); C07C 2102/08 (2013.01);
Abstract
A compound of formula I, wherein the groups R, R, R, X, m, and n are defined as in claim, which have valuable pharmacological properties, in particular bind to the GPR40 receptor and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2. Furthermore, the invention relates to novel intermediates, useful for the synthesis of compounds of formula I.